EMBC (Embecta Corp) Return on Sales by Gross Profit

EMBC (Embecta Health) - company brandmark

Despite full capacity utilization of automated lines and severe mold wear, Embecta Corp. relies on its global dominance in the diabetic injection niche and powerful lobbying. Historical gross margins clearly demonstrate the business's resilience, where 59.60 shows the value of this parameter. The critical importance of consumables allows the issuer to confidently index price lists while maintaining a high market share.

Embecta Corp. (EMBC): Gross Margin from 04/28/2023 to 11/19/2026

Comprehensive metric breakdowns and analytics for Embecta Corp. (EMBC)

- stock quotes and analyst forecast:
- business market valuation indicators:
Fundamental valuation:EMBC Embecta Corp
Finished products of Embecta Health

For Embecta Corp. (EMBC), which is optimizing resource consumption in the production of injection devices, the current value of 59.60 reflects the efficiency of direct cost management. By analyzing the gross profit margin, an investor assesses the portion of revenue remaining after cost of goods sold, where daily price action allows for the identification of anomalies and the determination of the business's operating cushion before deducting administrative expenses.

Main competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin PODD|Gross Margin zimmerbiomet.com (ZBH)|Gross Profitability CooperCompanies COO|Gross Margin Invisalign ALGN|GMED - Gross Profitability|TMDX: Gross Profitability|ATEC (Alphatec Holdings, Inc.) - Return on Gross Profit|Artivion, Inc. - Gross Profit Rate|ENOV (Enovis Inc.) - Gross Margin|Gross Profit Margin Integra LifeSciences Corp IART|Gross Profitability Establishment Labs Corp (ESTA)|Beta Bionics Inc (BBNX) - Gross Sales Margin|IRADIMED Inc. - Return on Gross Profit|Gross Margin Tandem Diabetes Care TNDM|AxoGen Inc - Gross Margin|Return on Sales by Gross Profit SI-BONE Inc SIBN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO